Low dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndrome (LILACS)

Back

ESC Premium Access

Low dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndrome (LILACS)

Session: Advances in Treatment of Acute Coronary Syndrome

Topic: Pharmacotherapy

Speaker: Doctor T. Zhao (Cambridge, GB)

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Doctor Tian Zhao

University of Cambridge, Cambridge (United Kingdom of Great Britain & Northern Ireland)

0 follower

5 more presentations in this session

Low-density lipoprotein cholesterol <50 mg/dL is an appropriate target after acute coronary syndrome: propensity score-matched analysis of the ODYSSEY OUTCOMES trial

Speaker: Professor G. Schwartz (Aurora, US)

Onyx ONE: Outcomes in patients with acute coronary syndrome

Speaker: Doctor E. Kedhi (Brussels, BE)

Differences in revascularization strategy and outcomes in ST-elevation and non-ST-elevation myocardial infarction with spontaneous coronary artery dissection

Speaker: Doctor T. Inohara (Tokyo, JP)

Prasugrel compared to ticagrelor in primary PCI

Speaker: Doctor J. Doerler (Klagenfurt, AT)

Sex disparities in completeness of revascularisation and outcomes in patients with ST-elevation myocardial infarction and multivessel coronary artery disease.

Speaker: Doctor N. Mahdi (Calgary, CA)

Access the full session

Advances in Treatment of Acute Coronary Syndrome

Speakers: Doctor T. Zhao, Professor G. Schwartz, Doctor E. Kedhi, Doctor T. Inohara, Doctor J. Doerler...

Access

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources